Press releases and News

2023-03-10 15:15 Regulatory
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION...
2023-03-09 15:30 Regulatory
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION...
2023-02-16 14:20 Regulatory
Senzime AB (publ) (”Senzime” or ”the Company”) announced on 23 February 2023 that the Board of Directors had resolved on a new issue of shares of approximately SEK 100 million with preferential right for existing shareholders (the...
2023-02-16 09:22 Regulatory
The extraordinary general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 16 February 2023, whereby the shareholders primarily resolved on the following matter. Resolution on the approval of the board of...
2023-02-09 10:15
The TetraSens® Pediatric sensor has received regulatory approval in Japan, further supporting the roll out of Senzime’s innovative patient monitoring systems Uppsala, February 9, 2023. Senzime AB (publ) today announced that the TetraGraph®...
2023-02-01 08:59 Regulatory
One of the leading pediatric hospitals in the US will implement Senzime’s quantitative neuromuscular monitoring system Uppsala, February 1, 2023. Senzime AB (publ) today announced that one of the leading pediatric hospitals in the US has decided...
2023-02-01 08:30 Regulatory Interim
Press release: Uppsala, 01 February 2022. Senzime AB's (publ) interim report for January - December 2022 is now available on the company's website www.senzime.com. Financial information October - December 2022 Financial information January - December...
2023-01-26 14:30
Senzime invites investors, analysts, and media to a presentation of the interim report for the fourth quarter 2022 on February 1, 14:00 CET. The report will be published at 8:30 CET the same day. During the presentation, Senzime’s CEO Pia Renaudin...
2023-01-23 19:19 Regulatory
Senzime AB (publ) (”Senzime” or the ”Company”) issues preliminary financial information for the fourth quarter 2022 with a general update of the Company’s financial and operational development and brings forward the announcement...
2023-01-23 19:17 Regulatory
The shareholders in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) are hereby convened to an extraordinary general meeting on Thursday 16 February 2023, at 08.30 at Advokatfirman Lindahl’s premises, Vaksalagatan 10, Uppsala...

Contact us

Want to know more?

How can Senzime’s innovative patient monitoring solutions help to eliminate in-hospital complications?
Contact us today.